Zhao, Ming http://orcid.org/0009-0005-9985-4448
DiPeri, Timothy P.
Raso, Maria Gabriela http://orcid.org/0000-0003-2105-5556
Zheng, Xiaofeng
Rizvi, Yasmeen Qamar
Evans, Kurt W.
Yang, Fei
Akcakanat, Argun
Roberto Estecio, Marco
Tripathy, Debu http://orcid.org/0000-0002-5711-2404
Dumbrava, Ecaterina E.
Damodaran, Senthil
Meric-Bernstam, Funda http://orcid.org/0000-0001-6816-6072
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54CA224065)
U.S. Department of Health & Human Services | National Institutes of Health (P30 CA016672)
The Nellie B. Connally Breast Cancer Research Endowment
Article History
Received: 17 January 2023
Accepted: 26 July 2023
First Online: 11 August 2023
Competing interests
: M.Z., T.P.D., M.G.R., X.Z., Y.Q.R., K.E., F.Y., A.A., and M.R.E. report no conflicts. D.T. reports Grant/contracts (paid to institution): Pfizer, Novartis, Polyphor Consultant: GlaxoSmithKline, AstraZeneca, OncoPep, Exact Sciences, Pfizer, Novartis, Personalis, Sermonix. E.E.D. reports consulting/advisory board fees from BOLT Therapeutics, Catamaran Bio, Mersana; sponsored research to the insitution from Bayer Healthcare, Immunocore, Amgen, NCI, Aileron Therapeutics, Compugen, TRACON Pharmaceuticals, Unum Therapeutics, Immomedics, BOLT Therapeutics, Aprea Therapeutics, Bellicum Pharmaceuticals, PMV Pharmaceuticals, Triumvira, Seagen, Mereo BioPharma 5 Inc, Sanofi, Astex. S.D. reports grant/research support (to the institution) from Guardant Health, Taiho, EMD Serano, Novartis, CPRIT, Sermonix; Membership on advisory committee for Taiho, ASCO, ABIM. F.M-B. reports receiving Consulting fees from AbbVie, Aduro BioTech Inc., Alkermes, AstraZeneca, Daiichi Sankyo Co. Ltd., DebioPharm, eFFECTOR Therapeutics, F. Hoffman-La Roche Ltd., Genentech Inc., Harbinger Health, IBM Watson, Infinity Pharmaceuticals, Jackson Laboratory, Kolon Life Science, Lengo Therapeutics, OrigiMed, PACT Pharma, Parexel International, Pfizer Inc., Protai Bio Ltd, Samsung Bioepis, Seattle Genetics Inc., Tallac Therapeutics, Tyra Biosciences, Xencor, Zymeworks; has served on Advisory Committees for Black Diamond, Biovica, Eisai, FogPharma, Immunomedics, Inflection Biosciences, Karyopharm Therapeutics, Loxo Oncology, Mersana Therapeutics, OnCusp Therapeutics, Puma Biotechnology Inc., Seattle Genetics, Sanofi, Silverback Therapeutics, Spectrum Pharmaceuticals, Zentalis; and Sponsored Research (to the institution) from Aileron Therapeutics, Inc. AstraZeneca, Bayer Healthcare Pharmaceutical, Calithera Biosciences Inc., Curis Inc., CytomX Therapeutics Inc., Daiichi Sankyo Co. Ltd., Debiopharm International, eFFECTOR Therapeutics, Genentech Inc., Guardant Health Inc., Klus Pharma, Takeda Pharmaceutical, Novartis, Puma Biotechnology Inc., Taiho Pharmaceutical Co. This work was supported by the following: The Nellie B. Connally Breast Cancer Research Endowment, The National Cancer Institute PDX Development and Trial Center (U54).